XELODA® (capecitabine) TABLETS
Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II Trial | Anticancer Research
Capecitabine dose-modification scheme | Download Table
Low-dose capecitabine adjuvant chemotherapy in elderly stage II/III colorectal cancer patients (LC-ACEC): study protocol for a randomized controlled trial | Trials | Full Text
VisualAbstract: Low-dose capecitabine after standard adjuvant therapy improves disease-free survival in patients with early triple-negative breast cancer | 2 Minute Medicine
Phase I/II Study of Ixabepilone plus Capecitabine
Quick Reference Guide - MRSA Topical Eradication
Phase I pharmacological study of continuous chronomodulated capecitabine treatment | SpringerLink
Capecitabine Teva Full Prescribing Information, Dosage & Side Effects | MIMS Thailand
P-121 Phase Ib trial of oxaliplatin, UGT1A1 genotype-directed dosing of irinotecan and chronomodulated capecitabine (OXIRI) chemotherapy in patients with advanced pancreatic cancer - Annals of Oncology
XELODA Dosage & Rx Info | Uses, Side Effects
XELODA® - Cancer Therapy Advisor
Celabin Dosage/Direction for Use | MIMS Philippines
National Dose Banding Table – Capecitabine
Capecitabine: Have We Got the Dose Right?
Capecitabine - wikidoc
Dosing & Administration - IXEMPRA® (ixabepilone) | Official patient site
Capecitabine dose calculation according to body surface area | Download Table
Capecitabine Tablets
![PDF] Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e7d901374eddb6500e1e3f83e8039d512de691b3/5-Table2-1.png "PDF] Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer. | Semantic Scholar")
PDF] Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer. | Semantic Scholar
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF | British
Cancers | Free Full-Text | Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214
Capecitabine Tablets, Dose:500 Mg at Rs 123/piece in Delhi | ID: 14833493930
Capecitabine as Salvage Therapy for a Pancreatic Cancer Patient with Extensive Liver Metastases and Associated Impairment of Liver Function
Capecitabine - wikidoc
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer | NEJM
